Mercedes Johnson, a director at Teradyne, Inc. (NASDAQ:TER), has executed a sale of 167 shares of the company's common stock. The transaction, which took place on July 1, 2026, resulted in a total value of $76,820. Each share was sold at a price of $460.00. The sale was facilitated through a Rule 10b5-1 trading plan, which Johnson originally adopted on March 4, 2026. This pre-arranged trading mechanism allows insiders to buy or sell company stock at predetermined times, removing the element of market timing from the decision.
Following the completion of this transaction, Johnson's direct holdings in Teradyne stand at 6,697 shares of common stock. Additionally, 1,876 shares are held indirectly through The Mercedes Johnson Trust. Johnson serves as both the trustee and the sole beneficiary of this trust, indicating continued indirect ownership and interest in the company's performance.
The insider sale occurs during a period of notable volatility and performance for Teradyne. Over the past year, the stock has delivered a substantial 355% return. However, recent market movements have seen shares decline by 9.5% over the last week. According to analysis provided by InvestingPro, the stock currently appears overvalued relative to its calculated Fair Value. Investors seeking detailed insights into Teradyne's valuation and performance metrics may access the comprehensive Pro Research Report, which is available for TER and over 1,400 other US equities.
Beyond insider activity, Teradyne has secured significant corporate contracts and strategic partnerships. The U.S. Department of War recently awarded Teradyne a $139.9 million contract to provide versatile diagnostic automatic test station kits. This agreement involves the assembly of standardized, commercially available test equipment, components, and software. Work related to this contract will be conducted at Robins Air Force Base in Georgia.
In the technology sector, Teradyne has announced a collaboration with Tokyo Electron to launch an integrated test cell solution for AI chips. This partnership combines Teradyne's UltraFLEXplus platform with Tokyo Electron's Prexa SDP, aiming to provide advanced device screening capabilities. These developments highlight the company's expansion into critical areas of semiconductor testing and artificial hardware infrastructure.
At the company's recent annual meeting, shareholders elected all nominated directors and approved key proposals. Aletheia has noted potential growth opportunities for Teradyne, specifically emphasizing the company's expansion in merchant GPU and co-packaged optics technology. To support shareholder returns, Teradyne declared a quarterly dividend of $0.13 per share. This dividend is payable in June 2026 to shareholders of record in May, reinforcing the company's engagement in maintaining shareholder value while expanding its technological capabilities.
Market data indicates that TER is included in AI-picked strategies. Real-time data shows a price of 369.09 USD, reflecting a decline of 58.25, or -13.63%. This data point underscores the recent downward pressure on the stock price despite its long-term performance. The combination of insider sales, valuation metrics, and corporate developments presents a complex picture for investors monitoring Teradyne's trajectory.